Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In response to growing concern surrounding delayed gastric emptying and aspiration risk, anesthesia societies and regulatory agencies have issued updated guidance addressing perioperative management of patients taking semaglutide and tirzepatide medications
We start at appropriate doses and adjust based on your response, maximizing results while minimizing side effects
Important clarification
Similarly, the European Medicines Agency (EMA) has not listed retatrutide as a medicine under active evaluation for marketing authorisation
GLP-1 medications are a class of medicines called glucagon-like peptide-1 receptor agonists
Digestive symptoms may begin during the first few weeks or after a research dose increase
